سعر انجيوسارتان 10مجم 28 قرص 2026

Olmesartan medoxomil 10 mg film-coated tablets (angiotensin II receptor blocker), pack of 28 tablets (4 strips), marketed in Egypt by Chemipharm.

• Treatment of essential hypertension in adultsPopulation: Adultselectronic medicines compendium (emc), UK
• Treatment of hypertension in children and adolescents from 6 to less than 18 yearsPopulation: Children 6-<18 yearselectronic medicines compendium (emc), UK

• Most commonly reported: headache (7.7%), influenza-like symptoms (4.0%) and dizziness (3.7%); dizziness the only reaction unequivocally treatment-related vs placebo (2.5% vs 0.9%).International label, same formulation · electronic medicines compendium (emc), UK

• Hypersensitivity to olmesartan medoxomil or excipients.International label, same formulation · electronic medicines compendium (emc), UK
• Second and third trimesters of pregnancy.International label, same formulation · electronic medicines compendium (emc), UK
• Biliary obstruction.International label, same formulation · electronic medicines compendium (emc), UK

• Symptomatic hypotension, especially after the first dose, in volume- and/or sodium-depleted patients; correct before administration.International label, same formulation · electronic medicines compendium (emc), UK
• Sprue-like enteropathy (severe chronic diarrhea with weight loss) reported months to years after starting olmesartan; consider alternative therapy if no other cause.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Hyperkalemia: monitor serum potassium, particularly with renal insufficiency, diabetes, or potassium-sparing diuretics/supplements.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• ColesevelamReduces olmesartan exposure; give olmesartan at least 4 hours before colesevelam.DailyMed (U.S. National Library of Medicine)
• LithiumIncreased serum lithium and toxicity reported; monitor lithium levels.DailyMed (U.S. National Library of Medicine)
• NSAIDs including COX-2 inhibitorsPossible deterioration of renal function and attenuated antihypertensive effect.DailyMed (U.S. National Library of Medicine)

• No information on presence in human milk; secreted at low concentration in rat milk; decide whether to discontinue nursing or the drug.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Olmesartan medoxomil: Prodrug hydrolysed to olmesartan, which blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II at the AT1 receptor.